Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:11 PM
Ignite Modification Date:
2025-12-24 @ 9:11 PM
NCT ID:
NCT04890704
Eligibility Criteria:
Inclusion Criteria:
* All the patients undergoing elective CAG at Vajira hospital from October 2018 to March 2019 were included in the study
* older than 18 years old
* stable eGFR 15-60 mL/min/1.73m2 in last 3 months.
Exclusion Criteria:
* dialysis-dependent
* post-kidney transplantation
* acute heart failure or critically ill
* history of contrast or turmeric allergy
* increasing of alanine aminotransferase (ALT) or alkaline phosphatase (ALP) more than three times of normal upper limits or post-cholecystectomy
* history of AKI (as evidence by sCr change ≥ 0.3 mg/dL) within 14 days before the study - using medication included NSAIDs, warfarin, immunosuppression, N-acetyl cysteine, ascorbic acid or contrast agents within 14 days before the study
* pregnancy or lactation o
* denied consent .
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT04890704
Study Brief:
Protocol Section:
NCT04890704